Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Prummer

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Oncotarget|October 15, 2016
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patientsMagdalena Lukamowicz-Rajska, Christiane Mittmann, Michael Prummer, et al.
Acta Neuropathologica|August 13, 2023
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survivalHans-Georg Wirsching, Jörg Felsberg, Michael Prummer, et al.
Nature Cell Biology|December 10, 2014
White-to-brown metabolic conversion of human adipocytes by JAK inhibitionAnnie Moisan, Youn-Kyoung Lee, Jitao David Zhang, et al.
Cell Chemical Biology|April 25, 2017
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug DiscoveryFaye Marie Drawnel, Jitao David Zhang, Erich Küng, et al.
Journal for Immunotherapy of Cancer|January 23, 2019
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancerLucia D'Amico, Ulrike Menzel, Michael Prummer, et al.
Cell Metabolism|September 13, 2011
Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and massDaria Esterházy, Ina Stützer, Haiyan Wang, et al.
Scientific Reports|March 23, 2019
Machine learning-powered antibiotics phenotypic drug discoverySannah Zoffmann, Maarten Vercruysse, Fethallah Benmansour, et al.
Plos Pathogens|April 7, 2020
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized miceNicole Caduff, Donal McHugh, Anita Murer, et al.
Plos Pathogens|December 21, 2020
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized miceNicole Caduff, Donal McHugh, Anita Murer, et al.
Cell Reports|December 2, 2014
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cellsFaye M Drawnel, Stefano Boccardo, Michael Prummer, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|October 15, 2016
MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patientsMagdalena Lukamowicz-Rajska, Christiane Mittmann, Michael Prummer, et al.
Acta Neuropathologica|August 13, 2023
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survivalHans-Georg Wirsching, Jörg Felsberg, Michael Prummer, et al.
Nature Cell Biology|December 10, 2014
White-to-brown metabolic conversion of human adipocytes by JAK inhibitionAnnie Moisan, Youn-Kyoung Lee, Jitao David Zhang, et al.
Cell Chemical Biology|April 25, 2017
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug DiscoveryFaye Marie Drawnel, Jitao David Zhang, Erich Küng, et al.
Journal for Immunotherapy of Cancer|January 23, 2019
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancerLucia D'Amico, Ulrike Menzel, Michael Prummer, et al.
Cell Metabolism|September 13, 2011
Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and massDaria Esterházy, Ina Stützer, Haiyan Wang, et al.
Scientific Reports|March 23, 2019
Machine learning-powered antibiotics phenotypic drug discoverySannah Zoffmann, Maarten Vercruysse, Fethallah Benmansour, et al.
Plos Pathogens|April 7, 2020
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized miceNicole Caduff, Donal McHugh, Anita Murer, et al.
Plos Pathogens|December 21, 2020
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized miceNicole Caduff, Donal McHugh, Anita Murer, et al.
Cell Reports|December 2, 2014
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cellsFaye M Drawnel, Stefano Boccardo, Michael Prummer, et al.
Pageof 4